Century Therapeutics

Century Therapeutics is an innovative biotechnology company building an industry-leading, allogeneic, iPSC-derived cell therapy platform that integrates cutting-edge gene editing, protein engineering, technical development and manufacturing capabilities to generate allogeneic, iPSC-derived therapies for autoimmune diseases, including type 1 diabetes, and cancer. The company is headquartered in Philadelphia, United States, and is publicly traded on NASDAQ under the ticker IPSC.

Century Therapeutics is a biotechnology company based in Philadelphia, United States. It is developing allogeneic, iPSC-derived cell therapies for autoimmune diseases, including type 1 diabetes, and cancer. The company is publicly traded on NASDAQ under the ticker IPSC.

• Unconfirmed

  Reported2020.07.15

  Century Therapeutics acquires Empirica Therapeutics[4]Century Therapeutics收购Empirica Therapeuticsutoronto.ca

  Empirica Therapeutics was acquired by Century Therapeutics. The acquired business is now known as Century Therapeutics Canada, and Century will further develop Empirica's proof-of-principle glioblastoma treatment.

Read more

1. 1Home | Century Therapeuticscenturytx.com
2. 2About | Century Therapeuticscenturytx.com
3. 3Century Therapeutics (United States)wikidata.org
4. 4Century Therapeutics收购Empirica Therapeuticsutoronto.ca